{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:04:46Z","timestamp":1771362286046,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.amjmed.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T01:25:39Z","timestamp":1642901139000},"page":"S49-S52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S1","title":["COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury"],"prefix":"10.1016","volume":"135","author":[{"given":"Zachary D.","family":"Crees","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Stockerl-Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjmed.2022.01.005_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2141.2001.02999.x","article-title":"Amyloidosis: a convoluted story","volume":"114","author":"Kyle","year":"2001","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.amjmed.2022.01.005_bib0002","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"136","author":"Palladini","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.amjmed.2022.01.005_bib0003","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.amjmed.2022.01.005_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL amyloidosis in Olmsted County, Minnesota, 1990 through 2015","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.005_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.amjmed.2022.01.005_bib0006","unstructured":"World Health Organization. Novel coronavirus (2019-nCoV) situation report \u20131. January 21, 2020. Available at: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200121-sitrep-1-2019-ncov.pdf. Accessed April 4, 2021."},{"key":"10.1016\/j.amjmed.2022.01.005_bib0007","unstructured":"Johns Hopkins University & Medicine, Coronavirus Resource Center. COVID-19 Dashboard. Available at: https:\/\/coronavirus.jhu.edu\/map.html. Accessed April 4, 2021."},{"issue":"2","key":"10.1016\/j.amjmed.2022.01.005_bib0008","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2169\/internalmedicine.9206-17","article-title":"Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in japan","volume":"57","author":"Shimazaki","year":"2018","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.amjmed.2022.01.005_bib0009","first-page":"472","article-title":"A modern primer on light chain amyloidosis in 592 patients with mass spectrometry\u2013verified typing","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"7821","key":"10.1016\/j.amjmed.2022.01.005_bib0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2022.01.005_bib0011","unstructured":"Centers for Disease Control and Prevention. COVID-19 risks and vaccine information for older adults. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/older-adults.html. Accessed April 4, 2021."},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.005_bib0012","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.amjmed.2022.01.005_bib0013","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.amjmed.2022.01.005_bib0014","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable sars-cov-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2022.01.005_bib0015","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/cid\/ciaa638","article-title":"Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples","volume":"71","author":"Bullard","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2022.01.005_bib0016","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2022.01.005_bib0017","unstructured":"US Food and Drug Administration (FDA). COVID-19 vaccines. Available at:https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines. Accessed April 4, 2021."},{"issue":"1","key":"10.1016\/j.amjmed.2022.01.005_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41375-020-01016-0","article-title":"Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network","volume":"35","author":"Ludwig","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.amjmed.2022.01.005_bib0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s43018-021-00191-y","article-title":"Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapy","volume":"2","author":"Thakkar","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.amjmed.2022.01.005_bib0020","unstructured":"International Myeloma Society. Recommendations for the management of myeloma patients during the COVID-19 pandemic. Available at: https:\/\/myeloma.wpengine.com\/wp-content\/uploads\/2021\/03\/PM-COVID-vaccination-in-MM-guidelines-The-Final.pdf. Accessed April 4, 2021."},{"key":"10.1016\/j.amjmed.2022.01.005_bib0021","unstructured":"American Society of Hematology. General principles of COVID-19 vaccines for immunocompromised patients. Available at: https:\/\/www.hematology.org\/covid-19\/ash-astct-covid-19-and-vaccines. Accessed April 4, 2021."},{"issue":"4","key":"10.1016\/j.amjmed.2022.01.005_bib0022","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbmt.2017.12.795","article-title":"Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance","volume":"24","author":"Palazzo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.amjmed.2022.01.005_bib0023","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1158\/1078-0432.CCR-11-1221","article-title":"Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses","volume":"18","author":"Noonan","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:26:12Z","timestamp":1757582772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":23,"alternative-id":["S0002934322000250"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.005","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}